{"id":"doi:10.1056/nejmoa1603827","kind":"article","title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","authors":["Steven P. Marso","Gilbert H. Daniels","Kirstine Brown‐Frandsen","Peter Lommer Kristensen","Johannes F.E. Mann","Michael Albrecht Nauck","Steven E. Nissen","Stuart Pocock","Neil R Poulter","Lasse Steen Ravn","William M. Steinberg","Mette Stockner","Bernard Zinman","Richard M. Bergenstal","John B. Buse"],"author_count":15,"year":2016,"published":"2016-06-13","venue":"New England Journal of Medicine","cited_by":7620,"doi":"10.1056/nejmoa1603827","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa1603827","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa1603827","updated":null,"pmid":"27295427","pmcid":"PMC4985288","openalex_id":"W2425644022","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1603827?articleTools=true","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}